1. [Safety and efficacy of percutaneous nephrolithotomy in patients with neurogenic bladder].
- Author
-
Chelghaf I, Glemain P, Madec FX, Loubersac T, de Vergie S, Branchereau J, Rigaud J, Perrouin-Verbe B, Lefort M, and Perrouin-Verbe MA
- Subjects
- Humans, Retrospective Studies, Treatment Outcome, Kidney Calculi complications, Kidney Calculi surgery, Nephrolithotomy, Percutaneous adverse effects, Nephrostomy, Percutaneous adverse effects, Urinary Bladder, Neurogenic complications, Urinary Bladder, Neurogenic surgery
- Abstract
Introduction: To assess the efficacy and morbidity of percutaneous nephrolithotomy (PNLT) in the treatment of renal stones in patients with neurogenic lower urinary tract dysfunction (NLUTD)., Methods: Retrospective, monocentric study including all patients with NLUTD who had undergone PNLT between 2005 and 2017. Pre-operative clinical data (neurological condition, voiding mode, preoperative urine culture…), peri-operative and post-operative data (success and morbidity) were collected from the patients' charts. Success was defined by the absence of residual fragment (RF), on imaging or intraoperative endoscopy. Partial efficacy was defined by the presence of RF lower than 4mm. Early complications were reported according to the Clavien-Dindo classification., Results: In all, 53 PNLTs were performed, in 35 patients, mostly with spinal cord injury. The success and partial efficacy rates were 66.0% and 71.7% respectively. The failure rate was correlated with increased stone burden (P=0.03), increased size of the largest stone (P=0.02), and the presence of complex stones (P<0.02). The rate of early complications was 41.5%, with 27.3% major, mostly septic, and bleeding. The retreatment rate within 3 years was 41.5%., Conclusion: In patients with NLUTD, PNLT allows a high success rate, but with a significant rate of retreatment and infectious complications. However, NLPC remains the gold standard in this population, especially for renal stones larger 20mm, allowing a higher success rate than ureteroscopy and a lower retreatment rate., (Copyright © 2022 Elsevier Masson SAS. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF